It is a chemicals and materials private limited company based in Chandigarh, Chandigarh, India, established in 1995.
1995 | Chandigarh, Chandigarh, India | ActiveKaizen Drugs Private Limited, a active private limited company, was established on 08 February 1995 in Chandigarh, Chandigarh, India. Engaging in industrial chemicals within the trade sector, it holds CIN: U24231CH1995PTC015776. Registered under ROC Roc Chandigarh. it is unlisted. It has an authorized capital of ₹3.00 M and a paid-up capital of ₹2.42 M.
Formerly known as Talson Drugs `Private Limited, Talson Drugs Private Limited. It upholds a compliant status. Employing 12 professional, Its leadership includes Shivali Khanduja (Whole-Time Director), Vivek Khanduja (Managing Director). Past directors included Krishan Lal Khanduja, Shivali Khanduja, Ranjana Khanduja. It holds ₹7.54 Cr open charges and ₹7.10 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Shop No 117/2, Old Mansa Devi Road,Manimajra, Chandigarh, Chandigarh, 160101.
U24231CH1995PTC015776
015776
08 February 1995
₹3.00 M
₹2.42 M
Roc Chandigarh
Unlisted
Active
Explore comprehensive insights into Kaizen Drugs Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Shivali Khanduja | Whole-Time Director | 11 May 2010 | Current |
| Vivek Khanduja | Managing Director | 15 Sep 2011 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 12 Nov 2017 | Past |
| Pramod Abcsdd | Director | 01 Apr 2015 | Past |
| Pramod Abcsdd | Director | 05 Apr 2015 | Past |
| Pramod Abcsdd | Additional Director | 30 Sep 2011 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Kaizen Drugs Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 42.89% increase. The company also saw a substantial improvement in profitability, with a 43.94% increase in profit. The company's net worth moved up by a moderate rise of 6.04%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Kaizen Drugs's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
₹75,379,000.00
₹71,000,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 29 Oct 2024 | Sidbi | ₹2.00 M | Open |
| 26 Jul 2024 | Others | ₹3.00 Cr | Open |
| 30 Mar 2024 | Others | ₹3.00 Cr | Open |
| 22 Nov 2023 | Sidbi | ₹1.81 M | Open |
| 02 Jan 2023 | Sidbi | ₹4.86 M | Open |
Explore comprehensive loan charge details -
Kaizen Drugs has a workforce of 12 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Kaizen Drugs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Kaizen Drugs's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on A charge with Sidbi amounted to Rs. 2.00 M with Charge ID 100994995 was registered on 29 Oct 2024. was documented.
Progress on Kaizen Drugs Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
Progress on A charge with Others amounted to Rs. 30.00 M with Charge ID 100974999 was registered on 26 Jul 2024. was documented.
Progress on A charge registered on 22 Jul 2019 via Charge ID 100277371 with Others was fully satisfied on 07 Jun 2024. was documented.
Progress on A charge registered on 13 Jan 2012 via Charge ID 10334770 with Oriental Bank Of Commerce was fully satisfied on 07 Jun 2024. was documented.
The activity A charge registered on 11 Jan 2000 via Charge ID 90180233 with Oriental Bank Of Commerce was fully satisfied on 07 Jun 2024. was completed.
The CIN of Kaizen Drugs Private Limited is U24231CH1995PTC015776.
Kaizen Drugs Private Limited is headquartered at Shop No 117/2, Old Mansa Devi Road,Manimajra, Chandigarh, Chandigarh, 160101.
Kaizen Drugs Private Limited was incorporated on 08 February 1995.
The current directors of Kaizen Drugs Private Limited are
The primary industry of Kaizen Drugs Private Limited is Trade.
Kaizen Drugs Private Limited is unlisted.
The authorized capital of Kaizen Drugs Private Limited is ₹3.00 M, and the paid-up capital is ₹2.42 M.
The compliance status of Kaizen Drugs Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX